Evaluation of risk factors for extrahepatic cholangiocarcinoma: ABO blood group, hepatitis B virus and their synergism.
about
HBV Infection Status and the Risk of Cholangiocarcinoma in Asia: A Meta-Analysis.Seroprevalence of transfusion transmitted infections among different blood group donors at Blood Bank LUMHS, HyderabadHepatitis B virus infection, diabetes mellitus, and their synergism for cholangiocarcinoma development: a case-control study in KoreaThe ABO blood group is an independent prognostic factor in patients with resected non-small cell lung cancer.Hepatitis B virus infection is associated with gastric cancer in China: an endemic area of both diseases.Smoking, alcohol consumption, and the risk of extrahepatic cholangiocarcinoma: a meta-analysis.Cholelithiasis and risk of pancreatic cancer: systematic review and meta-analysis of 21 observational studies.Diagnostic and prognostic serum marker of cholangiocarcinoma (Review)Hepatitis B virus infection is associated with younger median age at diagnosis and death in cancers.Systematic review and meta-analysis: cholecystectomy and the risk of cholangiocarcinoma.Distribution of ABO/Rh blood groups and their association with hepatitis B virus infection in 3.8 million Chinese adults: a population-based cross-sectional study.Smoking and risk of cholangiocarcinoma: a systematic review and meta-analysis.New insights into cholangiocarcinoma: multiple stems and related cell lineages of origin.Risk factors for perihilar cholangiocarcinoma: a hospital-based case-control study.Impact of nucleos(t)ide analog treatment on the development of malignancy in patients with chronic hepatitis B.
P2860
Q30240015-D41E923E-4207-40C6-B6D5-C754F92088E8Q33459277-824E8C92-5C81-47C8-B169-F1F5BD1853ACQ34932502-3615D740-B2B0-4CCE-9625-15C00FEF5909Q35028168-A40F480B-C420-4A23-8C87-C16EABC1E318Q35274812-A6ACED16-0A34-42ED-8EFB-20D728D51DB4Q37408907-99E04962-9411-4766-9137-B96F4809C593Q38242080-5A3E8EE0-9A2F-428C-A507-B618F125A628Q38272979-058EE8AD-3F48-463C-B8EF-BF2AB68E3827Q40261539-5EA50B06-1F5B-403D-A86E-E723CE820651Q41708799-331B78D5-6391-4122-A2DA-227C07C85F26Q45323948-A343746E-7992-4B7B-ABA1-D1D81D379ABDQ47141943-6F651724-5391-4CD6-8444-7E72D553838CQ50050635-F92CB839-A8A4-4B2F-B61D-2FA260A3FEFFQ53275564-6411E371-69CC-419E-B534-F3DF200CF687Q55514718-4B06B8A4-44CA-4F49-AEAA-101339A418C3
P2860
Evaluation of risk factors for extrahepatic cholangiocarcinoma: ABO blood group, hepatitis B virus and their synergism.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Evaluation of risk factors for ...... s B virus and their synergism.
@en
Evaluation of risk factors for ...... s B virus and their synergism.
@nl
type
label
Evaluation of risk factors for ...... s B virus and their synergism.
@en
Evaluation of risk factors for ...... s B virus and their synergism.
@nl
prefLabel
Evaluation of risk factors for ...... s B virus and their synergism.
@en
Evaluation of risk factors for ...... s B virus and their synergism.
@nl
P2093
P2860
P356
P1476
Evaluation of risk factors for ...... s B virus and their synergism.
@en
P2093
Quanbo Zhou
Ruiwan Chen
Yuanfeng Gong
P2860
P304
P356
10.1002/IJC.28196
P577
2013-05-08T00:00:00Z